One Health Biosensing

News

One Drop founder Jeff Dachis brought his new product out of stealth mode at Frontiers Health -- a CGM for use beyond Type 1 diabetes.

News

Jazz Pharma has dipped its toe into the M&A water again, agreeing to buy rare epilepsy drug developer Actio Bio for $820m upfront.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.